BACKGROUND: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family. OBJECTIVE: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP. DESIGN: A report of the clinical and pathological features in a familial tauopathy. SETTING: University of Minnesota. Patients We evaluated 2 siblings and clinically assessed 20 additional family members. MAIN OUTCOME MEASURES: Demonstration of salient features in deceased and living family members. RESULTS: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity. CONCLUSIONS: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.
BACKGROUND: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family. OBJECTIVE: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP. DESIGN: A report of the clinical and pathological features in a familial tauopathy. SETTING: University of Minnesota. Patients We evaluated 2 siblings and clinically assessed 20 additional family members. MAIN OUTCOME MEASURES: Demonstration of salient features in deceased and living family members. RESULTS: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity. CONCLUSIONS: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.
Authors: Shinsuke Fujioka; Bradley F Boeve; Joseph E Parisi; Pawel Tacik; Naoya Aoki; Audrey J Strongosky; Matt Baker; Monica Sanchez-Contreras; Owen A Ross; Rosa Rademakers; Vesna Sossi; Dennis W Dickson; A Jon Stoessl; Zbigniew K Wszolek Journal: Parkinsonism Relat Disord Date: 2014-08-19 Impact factor: 4.891
Authors: Hans H Jung; Juliane Bremer; Johannes Streffer; Kanwar Virdee; Maria Grazia Spillantini; R Anthony Crowther; Peter Brugger; Christine Van Broeckhoven; Adriano Aguzzi; Markus Tolnay Journal: Eur Neurol Date: 2012-01-18 Impact factor: 1.710
Authors: Mario Masellis; Kayla Sherborn; Pedro Neto; Dessa A Sadovnick; Ging-Yuek R Hsiung; Sandra E Black; Sadhana Prasad; Meghan Williams; Serge Gauthier Journal: Alzheimers Res Ther Date: 2013-07-31 Impact factor: 6.982
Authors: Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday Journal: Brain Date: 2018-02-01 Impact factor: 13.501
Authors: Helen Ling; Eleanna Kara; Tamas Revesz; Andrew J Lees; Gordon T Plant; Davide Martino; Henry Houlden; John Hardy; Janice L Holton Journal: Acta Neuropathol Commun Date: 2014-02-21 Impact factor: 7.801